Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dolutegravir sodium |
Is a |
False |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dolutegravir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dolutegravir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing abacavir and dolutegravir and lamivudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Dolutegravir- and rilpivirine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing dolutegravir and rilpivirine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dolutegravir (as dolutegravir sodium) 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolutegravir (as dolutegravir sodium) 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolutegravir sodium |
Is modification of (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Abacavir and dolutegravir and lamivudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only dolutegravir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dolutegravir and rilpivirine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dolutegravir and rilpivirine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dolutegravir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolutegravir- and lamivudine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dolutegravir and lamivudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dolutegravir and lamivudine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Dolutegravir- and lamivudine- and tenofovir-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely dolutegravir (as dolutegravir sodium) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dolutegravir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |